Pfizer Poised for Drop After 31% Rally Amid Covid Vaccine Push

(Bloomberg) -- Pfizer Inc.’s $48 billion gain in market value since late March, egged on by optimism for a successful Covid-19 vaccine, may soon hit a wall.